Rapport Therapeutics, Inc.
RAPP
$14.77
-$0.16-1.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.73M | -24.06M | -19.98M | -17.54M | -18.12M |
| Total Depreciation and Amortization | 252.00K | 244.00K | 260.00K | 219.00K | 208.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.78M | 4.02M | 3.93M | 1.38M | 1.68M |
| Change in Net Operating Assets | -3.37M | -433.00K | 1.34M | -477.00K | -123.00K |
| Cash from Operations | -25.07M | -20.24M | -14.45M | -16.42M | -16.35M |
| Capital Expenditure | -22.00K | -291.00K | -226.00K | -140.00K | -967.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.62M | 21.32M | 32.16M | -52.90M | -106.14M |
| Cash from Investing | 22.60M | 21.03M | 31.93M | -53.04M | -107.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 6.00K | 7.00K | -- | 159.10M |
| Repurchase of Common Stock | 0.00 | -1.00K | -- | -1.39M | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -29.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.00K | -- | -- | -- | 283.00K |
| Cash from Financing | -63.00K | 5.00K | 7.00K | -1.39M | 159.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.54M | 799.00K | 17.49M | -70.85M | 35.90M |